Abstract:Background: Melanoma is an aggressive tumor with a high mortality rate. Metformin, a commonly prescribed diabetes medication, has shown promise in cancer prevention and treatment. Long noncoding RNAs (lncRNAs) are non-protein-coding RNA molecules that play a key role in tumor development by interacting with cellular chromatins. Despite the benefits of metformin, the anticancer mechanism underlying its effect on the regulation of lncRNAs in melanoma remains unclear. Methods: We investigated the lncRNA profiles of human melanoma cells with and without metformin treatment using a next-generation sequencing approach (NGS). Utilizing public databases, we analyzed the expression levels and clinical impacts of LINC00094 and miR-1270 in melanoma. The expression levels of LINC00094 and miR-1270 were verified in human cell lines and clinical samples by real-time PCR and in situ hybridization. The biological roles of LINC00094 and miR-1270 in cell growth, proliferation, cell cycle, apoptosis, and motility were studied using in vitro assays. Results: We identify a novel long noncoding RNA, namely LINC00094, whose expression considerably decreased in melanoma cells after metformin treatment. In situ hybridization analysis revealed substantially higher expression of LINC00094 in cutaneous melanoma tissue compared with adjacent normal epidermis and normal control tissues (P < 0.001). In nondiabetic patients with melanoma, the overall survival of high LINC00094 expression group was shorter than the low LINC00094 expression group with borderline statistical significance (log-rank test, P = 0.057). Coexpression analysis of LINC00094 indicated its involvement in the mitochondrial respiratory pathway, with its knockdown suppressing genes associated with mitochondrial oxidative phosphorylation, glycolysis, antioxidant production, and metabolite levels. Functional analysis revealed that silencing-LINC00094 inhibited the proliferation, colony formation, invasion, and migration of melanoma cells. Cell cycle analysis following LINC00094 knockdown revealed G1 phase arrest with reduced cell cycle protein expression. Combined TargetScan and reporter assays revealed a direct link between miR-1270 and LINC00094. Ectopic miR-1270 expression inhibited melanoma cell growth and motility while inducing apoptosis. Finally, through in silico analysis, we identified two miR-1270 target genes, CD276 and centromere protein M (CENPM), which may be involved in the biological functions of LINC00094. Conclusions: Overall, LINC00094 expression may regulate melanoma cell growth and motility by modulating the expression of miR-1270, and targeting genes of CD276 and CENPM indicating its therapeutic potential in melanoma treatment.

LINC01063 Functions As an Oncogene in Melanoma Through Regulation of Mir-5194-mediated SOX12 Expression

LINC00662 Promotes Melanoma Progression by Competitively Binding Mir-107 and Activating the Β-Catenin Signaling Pathway.

LINC00467 Induces Melanoma Deterioration by Targeting Mir-485-5p/p21 Activated Kinase 1

Elevated LINC01550 induces the apoptosis and cell cycle arrest of melanoma

Long Non-Coding RNA LINC01296 Promotes Progression of Oral Squamous Cell Carcinoma Through Activating the MAPK/ERK Signaling Pathway Via the Mir-485-5p/pak4 Axis

LINC00152 Promotes the Growth and Invasion of Oral Squamous Cell Carcinoma by Regulating Mir-139-5p.

Long Noncoding RNA LINC00173 Promotes the Malignancy of Melanoma by Promoting the Expression of IRS4 Through Competitive Binding to Microrna-493.

SOX10 and microRNAs: decoding their interplay in regulating melanoma plasticity

Linc00961 Inhibits the Proliferation and Invasion of Skin Melanoma by Targeting the Mir‑367/pten Axis

YY1-induced lncRNA00511 promotes melanoma progression via the miR-150-5p/ADAM19 axis

LINC00612 Functions As a Cerna for Mir-214–5P to Promote the Proliferation and Invasion of Osteosarcoma in Vitro and in Vivo

Mir-24-3p Promotes Cell Migration and Proliferation in Lung Cancer by Targeting SOX7.

Identification and Functional Evaluation of Mir-4633-5p As a Biomarker and Tumor Suppressor in Metastatic Melanoma

Metformin regulates the proliferation and motility of melanoma cells by modulating the LINC00094/miR-1270 axis

LINC00460 Promotes Pancreatic Cancer Progression by Sponging Mir‐491‐5p

Upregulation LncRNA MEG3 expression suppresses proliferation and metastasis in melanoma via miR-208/SOX4

LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs

LINC00461/miR-4478/E2F1 Feedback Loop Promotes Non-Small Cell Lung Cancer Cell Proliferation and Migration.

Potential Involvement Of Mir-375 In The Premalignant Progression Of Oral Squamous Cell Carcinoma Mediated Via Transcription Factor Klf5

Long Noncoding RNA LINC01296 Induces Non-Small Cell Lung Cancer Growth and Progression Through Sponging Mir-5095

LINC01315 Impairs microRNA-211-Dependent DLG3 Downregulation to Inhibit the Development of Oral Squamous Cell Carcinoma